372 filings
8-K
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
8-K
BMY
Bristol-Myers Squibb Co.
18 Mar 24
Departure of Directors or Certain Officers
5:30pm
8-K
BMY
Bristol-Myers Squibb Co.
18 Mar 24
Strengthening Neuroscience Portfolio
8:56am
8-K
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
8-K
BMY
Bristol-Myers Squibb Co.
15 Feb 24
Departure of Directors or Certain Officers
4:57pm
8-K
j43gh9ud1
14 Feb 24
Bristol Myers Squibb Recommends Stockholders Reject “Mini-Tender” Offer by Tutanota LLC
4:32pm
8-K
3gni58 qg8mon
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
s9vavda
8 Jan 24
Regulation FD Disclosure
10:29am
8-K
3ioffdt4ag8sr6bdn10e
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
il5wu xxcsad
13 Nov 23
Other Events
4:19pm
8-K/A
alwd62a1cal29g
31 Oct 23
Departure of Directors or Certain Officers
4:30pm
8-K
wngtq0h pbzjl
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
zk8oyaqpozgflesv
10 Aug 23
Other Events
7:10am
8-K
tuubyfei8fcp4 6s
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
ofr37
4 May 23
Departure of Directors or Certain Officers
4:48pm
8-K
7mfmga
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
8-K
surz4z7tgi
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
8-K
4py60 aj2b
28 Feb 23
Other Events
6:55am
8-K
x6g7vj
2 Feb 23
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2022
8:43am
8-K
yqc8iw ig23qvf
31 Jan 23
Departure of Directors or Certain Officers
4:35pm